Codes / ICD10CM / T45.623

T45.623 Poisoning by hemostatic drug, assault

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by hemostatic drug, assault (ICD-10 code: T45.623)

Summary

This condition involves poisoning resulting from hemostatic drugs due to assault, where the exposure or overdose is inflicted by another individual. It includes toxic effects or adverse reactions caused by deliberate administration or forced ingestion of these agents, which are used to control bleeding or promote clot formation.

Causes

Assault-related poisoning may occur from intentional administration of hemostatic drugs by an external party, often as a means of harm. This can result from forced ingestion, injection, or exposure to these agents without consent. The intent is typically malicious, with the goal of causing injury or toxicity.

Risk Factors

  • Proximity to individuals with access to hemostatic medications.
  • Situations involving conflict or violence.
  • Vulnerable populations (e.g., those unable to resist or report harm).
  • Lack of supervision in environments where these drugs are stored or administered.

Symptoms

  • Excessive clotting (e.g., deep vein thrombosis, pulmonary embolism) or paradoxical bleeding.
  • Gastrointestinal or intracranial hemorrhage.
  • Signs of systemic toxicity (e.g., dizziness, confusion, hypotension).
  • Allergic reactions or anaphylaxis.
  • Nausea, vomiting, or abdominal pain.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, history of exposure, and confirmation of assault. Laboratory tests may assess drug levels, coagulation status, and organ function. Imaging or other diagnostic tools may be used to identify complications like thrombosis or hemorrhage.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing complications. This may include supportive care, antidotes (if available), or interventions to reverse clotting or bleeding. Psychological support and safety measures are also critical.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying health. Follow-up includes monitoring for delayed effects, assessing for trauma, and ensuring safety. Long-term care may involve rehabilitation or mental health support.

Complications

  • Severe bleeding or life-threatening thrombosis.
  • Organ damage (e.g., kidney, liver) from toxicity.
  • Psychological trauma or PTSD.
  • Recurrent health issues from prolonged exposure.

Lifestyle & Prevention

Prevention involves avoiding high-risk situations and ensuring secure storage of medications. Education on recognizing and reporting assault is important. Support systems and safety planning can reduce vulnerability.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., unusual bleeding, clotting, or toxicity) occur after suspected assault. Report the incident to authorities and healthcare providers promptly.

Tips for Medical Coders

Document the assault context clearly, including details of exposure and intent. Ensure the code T45.623 is used when poisoning by hemostatic drug is directly linked to assault. Verify that the clinical scenario aligns with the code’s definition to avoid miscoding.

Book a walkthrough

T45.623 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.